Drug
Antidepressant Cariprazine
Antidepressant Cariprazine: highest development phase Phase 2, developed by Gedeon Richter. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Gedeon Richter
Trials
| Drug | Phase | Indication |
|---|---|---|
| Antidepressant + cariprazine (0.1-0.3 mg/day) NCT00854100 | Phase 2 | Major Depressive Disorder |
Latest
No recent events.
Follow Antidepressant Cariprazine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.